Document is current
Any future updates will be listed below
-
Authors
Barron, Tara
Yalçın, Belgin https://orcid.org/0000-0001-9689-9062
Su, Minhui https://orcid.org/0000-0001-5803-6098
Byun, Youkyeong Gloria https://orcid.org/0000-0003-4669-0855
Gavish, Avishai
Shamardani, Kiarash https://orcid.org/0000-0002-2548-705X
Xu, Haojun
Ni, Lijun
Soni, Neeraj https://orcid.org/0000-0002-4191-6723
Mehta, Vilina https://orcid.org/0000-0002-5211-7505
Maleki Jahan, Samin
Kim, Yoon Seok
Taylor, Kathryn R. https://orcid.org/0000-0002-5110-8703
Keough, Michael B.
Quezada, Michael A. https://orcid.org/0000-0001-7307-5204
Geraghty, Anna C.
Mancusi, Rebecca https://orcid.org/0000-0002-4809-5569
Vo, Linh Thuy
Castañeda, Enrique Herrera
Woo, Pamelyn J.
Petritsch, Claudia K. https://orcid.org/0000-0002-3442-4974
Vogel, Hannes
Kaila, Kai https://orcid.org/0000-0003-0668-5955
Monje, Michelle https://orcid.org/0000-0002-3547-237X
- License Information
-
More Information
Article History
Received: 8 November 2022
Accepted: 26 December 2024
First Online: 19 February 2025
Change Date: 7 April 2025
Change Type: Update
Change Details: This paper was originally published under Creative Commons Attribution 4.0 International license, CC-BY-NC-ND, © The Author(s). It is now available under a Creative Commons Attribution 4.0 International license, CC-BY, © The Author(s). The error has been corrected in the online version of the article.
Competing interests
: M.M. holds equity in MapLight Therapeutics and Stellaromics, and stock in CARGO Therapeutics. The other authors declare no competing interests.
